Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light

This study has been completed.
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00432224
First received: February 6, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted

February 6, 2007
February 6, 2007
May 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light
Not Provided

The objective of the study is to evaluate the use of sunlight instead of red light during photodynamic therapy of actinic keratoses using methyl aminolevulinate

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Actinic Keratoses
Procedure: photodynamic therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
28
February 2007
Not Provided

Inclusion Criteria:

  • symmetric actinic keratoses in scalp or face

Exclusion Criteria:

  • porphyria, pregnancy, breast feeding
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Denmark
 
NCT00432224
KF 01-272867
Not Provided
Not Provided
Bispebjerg Hospital
Not Provided
Study Director: Hans Christian Wulf, Professor, MD Bispebjerg Hospital
Study Chair: Merete Hædersdal, MD, PhD Bispebjerg Hospital
Bispebjerg Hospital
February 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP